References
Fujinaga S, Nishino T (2016) Ten-year treatment with mycophenolate mofetil using therapeutic drug monitoring for childhood-onset lupus nephritis in Japan. Pediatr Nephrol. doi:10.1007/s00467-016-3507-1
Rianthavorn P, Buddhasri A (2015) Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis. Pediatr Nephrol 30:1969–1976
Kittanamongkolchai W, Rukrung C, Supasiri T, Lertjirachai I, Somparn P, Chariyavilaskul P, Avihingsanon Y (2013) Therapeutic drug monitoring of mycophenolate mofetil for the treatment of severely active lupus nephritis. Lupus 22:727–732
Acknowledgments
The author gratefully acknowledges Kevin P. Jones for English editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The author hereby declares no personal or professional conflicts of interest regarding any aspect of this study.
Rights and permissions
About this article
Cite this article
Rianthavorn, P. Response to comments from Fujinaga and Nishino regarding the article “Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis”. Pediatr Nephrol 32, 191–192 (2017). https://doi.org/10.1007/s00467-016-3508-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-016-3508-0